Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563

By Langrehr J.M.   Lohmann R.   Raakow R.   Jonas S.   Klupp J.   Bechstein W.O.   Neuhaus R.   Neuhaus P.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2290-2291

Elsevier

Access to resources Recommend Favorite

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients

By Nashan B.   Schwinzer R.   Schlitt H.   Wonigeit K.   Pichlmayr R.  

Transplant Immunology, Vol. 3, Iss. 3, 1995-09 ,pp. : 203-211

Elsevier

Access to resources Recommend Favorite

A Randomized Trial Comparing Anti-Interleukin-2 Receptor Antibody and Placebo for Immunosuppressive Therapy After OLT

By Langrehr J.M.   Glanemann M.   Schneller A.   Neumann U.   Guckelberger O.   Lohmann R.   Klupp J.   Jonas S.   Knoop M.   Lobeck H.   Schlag H.   Keck H.   Settmacher U.   Bechstein W.O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1445-1446

Elsevier

Access to resources Recommend Favorite

Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial

By Langrehr J.M.   Klupp J.   Junge G.   Jonas S.   Neuhaus R.   Bechstein W.O.   Neuhaus P.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2330-2331

Elsevier

Access to resources Recommend Favorite

First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV

By Langrehr J.M.   Neumann U.P.   Lang M.   Muller A.R.   Jonas S.   Settmacher U.   Steinmuller T.   Neuhaus P.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1565-1566

Elsevier

Access to resources Recommend Favorite